Global - What we do - Industries - Pharmaceuticals

Pharmaceuticals 

KPMG’s global Pharmaceuticals practice is dedicated to assisting businesses of all sizes from biotechnology start-ups to large multinational pharmaceutical companies.

KPMG's Risk and Disclosures Handbook 2008-09: Global Pharmaceuticals, Medical Devices and Diagnostics, and Biotechnology Industries

For the seventh year, KPMG has analyzed and compared some of the largest companies in the Pharmaceutical, Medical Devices and Diagnostics, and Biotechnology industries for the 2008-2009 reporting season.

Contact

John Morris

John Morris

Global Chair, Chemicals & Pharmaceuticals

+44 207 311 1000

gofmdotcomchems@kpmg.com
Our services are tailored to the issues that the industry ― and your company ― experience. Our member firms’ professionals have already helped many companies with these issues:
  • sales force compliance
  • pricing compliance
  • business model operating structure
  • operational efficiency
  • change management
  • supply chain management
  • fraud and intellectual property
  • innovation and research and development
  • competition from generics
  • mergers, acquisitions and disposals
  • market entry and expansion
  • emerging market companies.

KPMG’s industry-focused professionals have experience in the pharmaceutical sector; they continuously strive to keep abreast of industry trends, drivers and issues through knowledge sharing and industry insights programs. Our global network aims to ensure that KPMG firms serve you with the same level of quality and consideration, whether you are operating in fast growing or emerging markets in the Americas, Asia or Europe.
  • Sign up now

Subscribe to selected content and receive email alerts when new content is available for viewing on this site.

Already a member? Login

Not a member? Register

Or find a contact in your location

Go

  • Subscribe to related feeds